Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns

Journal of Perinatology

Volumn 32, Issue 9, 2012, Pages 677-684

  Tyson, J E ^a   Pedroza, C ^a   Langer, J ^b   Green, C ^a   Morris, B ^c   Stevenson, D ^d   Van Meurs, K P ^d   Oh, W ^e   Phelps, D ^f   O'Shea, M ^g   McDavid, G E ^a   Grisby, C ^h   Higgins, R ⁱ  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b RTI INTERNATIONAL   (United States)

^c Trinity Mother Frances Hospitals and Clinics   (United States)

^d STANFORD UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF ROCHESTER   (United States)

^g WAKE FOREST UNIVERSITY   (United States)

^h UNIVERSITY OF CINCINNATI   (United States)

ⁱ EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Bayesian analysis; bilirubin; ELBW infant; phototherapy; randomized clinical trial; statistical interaction

Indexed keywords

BILIRUBIN;

AGGRESSIVE PHOTOTHERAPY; ARTICLE; ARTIFICIAL VENTILATION; BAYES THEOREM; BILIRUBIN BLOOD LEVEL; CONSERVATIVE PHOTOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; EXTREMELY LOW BIRTH WEIGHT; HEALTH HAZARD; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; OUTCOME ASSESSMENT; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; PHOTOTHERAPY; RESPIRATION, ARTIFICIAL; SEVERITY OF ILLNESS INDEX;

EID: 84865767697     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2012.64     Document Type: Article

References (38)

1. Lucey JF. Fetal infants: thoughts about what to do. Pediatrics 2004; 113(6): 1819. (Pubitemid 38698001)
2. Oh W, Tyson JE, Fanaroff AA, Vohr BR, Perritt R, Stoll BJ et al. Association between peak serum bilirubin and neurodevelopmental outcomes in ELBW infants. Pediatrics 2003; 112(4): 773-779. (Pubitemid 37248682)
3. Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O'Shea TM et al. Aggressive vs. conservative phototherapy for infants with ELBW. N Engl J Med 2008; 359(18): 1885-1896.
4. Brown AK, Kim MH, Wu PYK, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985; 75(2, Part 2): 393-400. (Pubitemid 15172368)
5. Lipsitz PJ, Gartner LM, Bryla DA. Neonatal and infant mortality in relation to phototherapy. Pediatrics 1985; 75(2, Part 2): 422-426. (Pubitemid 15172373)
6. Maisels MJ. Chapter 22. Neonatal jaundice In: Sinclair JC, Bracken MB (eds). Effective Care of the Newborn Infant. Oxford University Press: Oxford, UK, 1992, Table 47, p 532.
7. Maisels MJ. Neonatal hyperbilirubinemia In: Klaus MH, Fanaroff AA (eds). Care of the High-risk Neonate, 5th edn. WB Saunders: Philadelphia, 2001; 324-362.
8. Gopinathan V, Miller NJ, Milner AD, Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 1994; 349(2): 197-200. (Pubitemid 24263261)
9. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235(4792): 1043-1046. (Pubitemid 17049750)
10. Tozzi E, Tozzi-Ciancarelli MG, Di Giulo A, D'Alfonso A, Farello G, Spennati GF et al. In vitro and in vivo effects of erythrocyte phototherapy on newborns. Biol Neonate 1989; 56(4): 204-209. (Pubitemid 19247330)
11. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol 2004; 28(5): 326-333. (Pubitemid 39626114)
12. Roll EB, Christensen T. Formation of photoproducts and cytotoxicity of bilirubin irradiated with turquoise and blue phototherapy light. Acta Paediatr 2005; 94: 1448-1454, 1360-2. (Pubitemid 41510657)
13. Wennberg RP. The blood-brain barrier and bilirubin encephalopathy. Cell Mol Neurobiol 2000; 20(1): 97-109. (Pubitemid 30090918)
14. Hansen TWR. Mechanisms of bilirubin toxicity: clinical implications. Clin Perinatol 2002; 29(4): 765-778. (Pubitemid 36076381)
15. Bender GJ, Cashore WJ, Oh W. Ontogeny of bilirubin-binding capacity and the effect of clinical status in premature infants born at less than 1300 grams. Pediatrics 2007; 120(5): 1067-1073. (Pubitemid 350085541)
16. Spiegelhalter DJ, Myles JP, Jones DR, Abrams KR. An introduction to Bayesian methods in health technology assessment. BMJ 1999; 319(7208): 508-512.
17. Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: A way out of a conundrum. BMJ 1995; 311(7020): 1621-1625. (Pubitemid 26002712)
18. Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol 2009; 62(1): 13-21.e5.
19. Vohr BR, Wright LL, Poole WK, McDonald SA. Neurodevelopmental outcomes of ELBW infants 32 weeks' gestation between 1993 and 1998. Pediatrics 2005;116(3):635-643 (Pubitemid 44336680)
20. Bayley N. Bayley Scales of Infant Development II. Psychological Corporation: New York, NY, 1993.
21. Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol 1997; 39(4): 214-223. (Pubitemid 27226331)
22. Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, Wilson-Costello D et al. Poor predictive validity of the Bayley Scales of Infant Development for cognitive function of ELBW children at school age. Pediatrics 2005; 116: 333-341. (Pubitemid 44161457)
23. Tyson JE, Parikh NA, Langer J, Green C, Higgins RD. Intensive care for extreme prematurityFmoving beyond gestational age. N Engl J Med 2008; 358(16): 1672-1681. (Pubitemid 351549914)
24. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1(1): 43-46. (Pubitemid 20255621)
25. Dixon DO, Simon R. Bayesian subset analysis. Biometrics 1991; 47(3): 871-881.
26. Sinclair JC, Haughton DE, Bracken MB, Horbar JD, Soll RF. Cochrane neonatal systematic reviews: A survey of the evidence for neonatal therapies. Clin Perinatol 2003; 30(2): 285-304. (Pubitemid 36807749)
27. Jones HE, Ohlssen DI, Neuenschwander B, Racine A, Branson M. Bayesian models for subgroup analysis in clinical trials. Clin Trials 2011; 8(2): 129-143.
28. Sung L, Hayden J, Greenberg ML, Koren G, Feldman BM, Tomlinson GA. Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol 2005; 58: 261-268. (Pubitemid 40249468)
29. Silverman WA. Human experimentation in perinatology. Clin Perinatol 1987; 14: 403-416. (Pubitemid 17111152)
30. Kraemer HC, Frank E. Evaluation of comparative treatment trials. Assessing clinical benefits and risks for patients, rather than statistical effects on measures. JAMA 2010; 304(6): 683-684.
31. Oxman A, Guyatt G. Summarizing the evidence: When to believe a subgroup analysis In: Guyatt G, Drummond R (eds). Users' Guides To The Medical Literature: A Manual For Evidence-Based Clinical Practice. AMA Press: Chicago, IL, 2002, pp 553-565.
32. McGrayne SB. The Theory That Would Not Die. Yale University Press: New Haven, CT, 2011.
33. Goodman SN. Introduction to Bayesian methods I: measuring the strength of evidence. Clin Trials 2005; 2(4): 282-290. (Pubitemid 41306268)
34. Torrance GW, Feeny DH, Furlong WJ, Barr RD, Zhang Y, Wang Q. Multiattribute utility function for a comprehensive health status classification: Health Utilities Index Mark 2. Med Care 1996; 34(7): 702-722. (Pubitemid 126433265)
35. Saigal S, Stoskopf BL, Burrows E, Streiner DL, Rosenbaum PL. Stability of maternal preferences for pediatric health states in the perinatal period and 1 year later. Arch Pediatr Adolesc Med 2003; 157(3): 261-269. (Pubitemid 36343381)
36. Oh W, Stevenson DK, Tyson JE, Morris BH, Ahlfors CE, Bender GJ et al. Influence of clinical status on the association between plasma total and unbound bilirubin and death or adverse neurodevelopmental outcomes in ELBW infants. Acta Paediatr 2010; 99(5): 673-678.
37. Watchko JF, Maisels MJ. Enduring controversies in the management of hyperbilirubinemia in preterm infants. Sem Fetal Neonatal Med 2010; 15: 136-140.
38. Wong RJ, Bhutani VK, Vreman HJ, Stevenson DK. Tin mesoporphyrin for the prevention of severe neonatal hyperbilirubinemia. NeoReviews 2007; 8(2): 77-84.